DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia
July 22 2021 - 9:05AM
Diagnos Inc. (“
DIAGNOS” or the
“
Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA:
4D4A), a leader in early detection of critical health issues, is
pleased to announce the official opening of the initial clinics at
the Magrabi Hospital.
Dr. Ibrahim Al-Omar, Undersecretary of the
Ministry of Health for Investment, inaugurated last Wednesday the
early detection unit for diabetic retinopathy operated by DIAGNOS’
AI (Artificial Intelligence) technology at Magrabi Eye, Ear and
Dental Hospital in Riyadh, the first of its kind in the Kingdom.
The inauguration was attended by the executive management of the
Magrabi Group represented by Mr. Mutasim Alireza, Managing
Director, Dr. Tariq Al-Hamad, Regional Operations Director, Senior
Retinal Consultants, Yves-Stephane Couture, Vice President of
DIAGNOS and members of the management of Kanhoor Company and Bayer
Pharmaceuticals.
When asked, Dr. Walid bin Abdul Rahman Al-Turki,
head of the retinal departments at Magrabi Group in Riyadh, stated
that the aim of this unit is to examine the largest possible number
of diabetic patients who are at risk of developing retinal diseases
associated with them, which unfortunately may end in a gradual
complete loss of vision. It is known that the incidence of diabetes
in the Kingdom is about 27% of the population, which indicates the
extent of the potential risk. At the conclusion of the interview,
Dr. Walid Al-Turki stated that the initiative is in its infancy,
and the Magrabi Group will develop and circulate it in all branches
upon completion of its review.
Magrabi Hospitals and Centers has thirty-four
branches in the Middle East; Twenty-two of them are in the Kingdom
in Riyadh, Jeddah, Makkah, Dammam, Khobar, Al-Ahsa, Jubail, Asir,
Jazan, Madinah, and Qassim. Magrabi Hospitals and Centers Group was
established in Jeddah in 1955 as the first hospital specialized in
ophthalmology, and today it is the largest specialized medical
network in the region.
The event was reported by the SABQ online
newspaper (sabq.org) and the link is attached:
https://mobile.sabq.org/gJxtfn
“We extend our best wishes to Magrabi hospitals.
We would also like to thank everyone in attendance for their time
and efforts in making this project a reality. The main
beneficiaries will be many thousands of diabetic patients whose
vision can now be protected through this collaboration,” said
André Larente, President of DIAGNOS.
About DIAGNOS:DIAGNOS is a
publicly traded Canadian corporation dedicated to early detection
of critical health problems based on its FLAIRE Artificial
Intelligence (AI) platform. FLAIRE allows for quick modifying and
developing of applications such as CARA (Computer Assisted Retina
Analysis). CARA’s image enhancement algorithms provide sharper,
clearer and easier-to-analyze retinal images. CARA is a
cost-effective tool for real-time screening of large volumes of
patients. CARA has been cleared for commercialization by the
following regulators: Health Canada, the FDA (USA), CE (Europe),
COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).
Additional information is available at
www.diagnos.com and www.sedar.com
This news release contains forward-looking
information. There can be no assurance that forward-looking
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in these
statements. DIAGNOS disclaims any intention or obligation to
publicly update or revise any forward-looking information, whether
as a result of new information, future events or otherwise. The
forward-looking information contained in this news release is
expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/8a7ffa81-96b1-490d-872f-6deffc109420
For further information, please contact:
Mr. André Larente, President
DIAGNOS Inc.
Tel: +1-450-678-8882 ext. 224
Email: alarente@diagnos.ca
Corporate Communications:
Nancy Massicotte
IR Pro Communications Inc.
Dir: +1 604-507-3377
TF: 1-866-503-3377
Email: nancy@irprocommunications.com
Diagnos (TSXV:ADK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Diagnos (TSXV:ADK)
Historical Stock Chart
From Jul 2023 to Jul 2024